Sequoia Financial Advisors LLC Has $927,000 Position in Humana Inc. $HUM

Key Points

• Sequoia Financial Advisors LLC has increased its stake in Humana Inc. by 112.3% to a total of 3,790 shares, valued at $927,000 as of the last quarter.
• Humana reported $6.27 earnings per share for the last quarter, which was below analysts' expectations, but the company had a revenue of $32.39 billion, surpassing the forecast.
• Humana announced a quarterly dividend of $0.885 per share, set to be paid on October 31st, reflecting an annualized yield of 1.3%.

Sequoia Financial Advisors LLC lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 112.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,790 shares of the insurance provider's stock after purchasing an additional 2,005 shares during the period. Sequoia Financial Advisors LLC's holdings in Humana were worth $927,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Garde Capital Inc. acquired a new stake in shares of Humana in the first quarter valued at approximately $36,000. Zions Bancorporation National Association UT acquired a new stake in shares of Humana in the first quarter valued at approximately $37,000. Ransom Advisory Ltd acquired a new stake in shares of Humana in the first quarter valued at approximately $66,000. Finally, Transamerica Financial Advisors LLC increased its holdings in shares of Humana by 1,027.6% in the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider's stock valued at $87,000 after purchasing an additional 298 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Trading Up 2.9%

Shares of NYSE HUM opened at $275.00 on Friday. The company's fifty day moving average is $280.54 and its 200-day moving average is $258.23. The stock has a market cap of $33.07 billion, a price-to-earnings ratio of 21.11, a P/E/G ratio of 1.56 and a beta of 0.42. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $315.35. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the prior year, the business earned $6.96 earnings per share. The company's revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio (DPR) is presently 27.17%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Mizuho raised their price objective on shares of Humana from $300.00 to $345.00 and gave the company an "outperform" rating in a research note on Thursday, October 9th. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Bank of America raised their price objective on shares of Humana from $280.00 to $300.00 and gave the company a "neutral" rating in a research note on Friday, October 10th. Wolfe Research raised their price objective on shares of Humana from $283.00 to $313.00 and gave the company an "outperform" rating in a research note on Monday, October 6th. Finally, Barclays reduced their price objective on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating on the stock in a research note on Friday, October 3rd. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $297.58.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.